Anti-Anthrax Drug Gets AIDAC Recommendation on Resubmission

A A
The FDA’s Anti-Infective Drugs Advisory Committee on Nov. 2 recommended approval of GlaxoSmithKline’s (GSK) 40-mg/kg raxibacumab IV solution, with or without an antimicrobial, to treat adults infected in an airborne anthrax attack.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00